Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome

Catastrophic antiphospholipid syndrome is associated with excessive complement activation explaining the clinical efficacy of complement inhibitory treatment.

Saved in:
Bibliographic Details
Published inRheumatology (Oxford, England) Vol. 55; no. 7; pp. 1337 - 1339
Main Authors Barratt-Due, Andreas, Fløisand, Yngvar, Orrem, Hilde L, Kvam, Ann K, Holme, Pål A, Bergseth, Grethe, Tjønnfjord, Geir E, Mollnes, Tom E
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.07.2016
Subjects
APS
CAPS
Catastrophic antiphospholipid syndrome
clinical efficacy
Clinical medical disciplines: 750
Eculizumab
Letters to the Editor
Medical disciplines: 700
pathophysiology
Rheumatology: 759
treatment
VDP
Online AccessGet full text

Cover

More Information
Summary:Catastrophic antiphospholipid syndrome is associated with excessive complement activation explaining the clinical efficacy of complement inhibitory treatment.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Volume 55, Issue 7
ISSN:1462-0324
1462-0332
1462-0332
DOI:10.1093/rheumatology/kew040